Although I am not a medical scientist, IMO this share price result would only be applicable if the trial showed no effect or severe adverse side effects and did not treat acne at all. The announcement does not say that at all - unless of course I am missing something. I would like to think the BOT management are preparing another announcement pronto to clarify the results. I brought more because I only see positives here excluding what appears to be an error with the USA results.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-69
-
- There are more pages in this discussion • 582 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.015(4.00%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.0¢ | 36.0¢ | $1.728M | 4.749M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 220425 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 212945 | 8 |
View Market Depth
| Last trade - 13.53pm 31/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |